Today, San Francisco-based Triomics, a startup looking to accelerate cancer care with generative AI, announced its $15 million from Lightspeed, Nexus Venture Partners, General Catalyst and Y ...

Triomics recently also published the results of its information retrieval engine for oncology, which they found to be 1.5-2 times better than other state-of-the-art retrieval models. Story Continues ...

Triomics, an oncology-focused artificial intelligence company, raised $15 million to help automate cancer providers’ workflows. Investors supporting the round include Lightspeed, Nexus Venture ...

Triomics was founded by former MIT biotech researcher Sarim Khan and AI scientist at Adobe Hrituraj Singh. The pair, who have been friends since college, decided to build Triomics in 2021 after ...